Building on sociological understandings of the pharmaceutical industry or reinventing the wheel? Response to Joan Busfield's 'pills, power, people'

Sociology

Volumn 41, Issue 4, 2007, Pages 727-736

  Abraham, John ^a,b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b Arts D Building   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548288511     PISSN: 00380385     EISSN: None     Source Type: Journal    
DOI: 10.1177/0038038507078929     Document Type: Review

References (32)

1. Abraham, J. (1993) ' Scientific Standards and Institutional Interests: Carcinogenic Risk Assessment of Benoxaprofen in the UK and the US', Social Studies of Science 23: 387 - 444.
2. Abraham, J. (1994) ' Bias in Science and Medical Knowledge: The Opren Controversy', Sociology 28: 717 - 36.
3. Abraham, J. (1995 a) Science, Politics and the Pharmaceutical Industry London: UCL Press.
4. Abraham, J. (1995 b) ' The Production and Reception of Scientific Papers in the Academic-Industrial Complex: The Clinical Evaluation of New Medicines', British Journal of Sociology 46: 167 - 90.
5. Abraham, J. (1997) ' The Science and Politics of Medicines Regulation ', in M.A. Elston (ed.) Sociology of Health & Illness Special Monograph Issue on the Sociology of Medical Science and Technology, pp. 153 - 82. Oxford: Blackwell.
6. Abraham, J. (2002 a) 'Transnational Industrial Power, the Medical Profession and the Regulatory State', Social Science & Medicine 55: 1671 - 90.
7. Abraham, J. (2002 b) ' The Pharmaceutical Industry as Political Player', Lancet 360: 1498 - 502.
8. Abraham, J. and C. Davis (2005) 'A Comparative Analysis of Drug Safety Withdrawals in the UK and the US (1971-1992). Implications for Current Regulatory Thinking and Policy', Social Science & Medicine 61: 881 - 92.
9. Abraham, J. and T. Reed (2001) ' Trading Risks for Markets: The International Harmonisation of Pharmaceutical Regulation', Health, Risk & Society: Special Issue on Globalisation 3: 113 - 28.
10. Abraham, J. and T. Reed (2003) 'Globalization of Medicines Control', in J. Abraham and H. Lawton Smith (eds) Regulation of the Pharmaceutical Industry, pp. 82 - 107. Basingstoke: Palgrave.
11. Abraham, J. and J. Sheppard (1998) ' International Comparative Analysis and Explanation in Medical Sociology: Demystifying the Halcion Anomaly ', Sociology 32: 141 - 62.
12. Abraham, J. and J. Sheppard (1999) ' Complacent and Conflicting Scientific Expertise in British and American Drug Regulation ', Social Studies of Science 29: 803 - 44.
13. Bowe, C. (2004) 'FDA Official Warns on more Drugs in Hearing', Financial Times 19 November.
14. Braithwaite, J. (1984) Corporate Crime in the Pharmaceutical Industry. London: Routledge.
15. Braithwaite, J. and P. Drahos (2000) Global Business Regulation. Cambridge: Cambridge University Press.
16. Bury, M. and J. Gabe (1996) ' Halcion Nights: A Sociological Account of a Medical Controversy ', Sociology 30: 447 - 69.
17. Busfield, J. (2006) 'Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry', Sociology 40: 297 - 314.
18. Daemmrich, A. (2004) Pharmacopolitics: Drug Regulation in the US and Germany. Chapel Hill: University of North Carolina Press.
19. Epstein, S. (1996) Impure Science: AIDS, Activism and the Politics of Knowledge Berkeley: University of California Press.
20. Gabe, J. and M. Bury (1996) 'Anxious Times: The Benzodiazepine Controversy and the Fracturing of Expert Authority', in P. Davis (ed.) Contested Ground: Public Purpose and Private Interest in the Regulation of Prescription Drugs, pp. 42 - 56. New York: Oxford University Press.
21. Gijswijt-Hofstra, M., G.M. Van Hetren and E.M. Tansey (eds) (2002) Biographies of Remedies: Drugs, Medicines and Contraceptives in Dutch and Anglo-American Healing Cultures. Amsterdam: Rodopi.
22. Hedgecoe, A. and P. Martin (2003) ' The Drugs Don't Work', Social Studies of Science 33: 327 - 64.
23. House of Commons (2005) The Influence of the Pharmaceutical Industry. Health Committee - Fourth Report of Session 2004-5, Vol. 1.
24. Lakoff, A. (2004) ' The Anxieties of Globalisation: Antidepressant Sales and Economic Crisis in Argentina', Social Studies of Science 34: 247 - 70.
25. Latour, B. (1987) Science in Action. Cambridge, MA: Harvard University Press.
26. Liebenau, J. (1987) Medical Science and Medical Industry. Baltimore, MD: Johns Hopkins University Press.
27. Marks, L. (1997) The Progress of Experiment: Science and Therapeutic Reform in the US, 1900-1990. Cambridge: Cambridge University Press.
28. Pieters, T. (2004) 'Hailing a Miracle Drug: The Interferon', in W. de Blecourt and C. Usborne (eds) Cultural Approaches to the History of Medicine, pp. 212 - 32. Basingstoke: Palgrave.
29. Rasmussen, N. (2004) ' The Moral Economy of the Drug Company-Medical Scientist Collaboration in Interwar America', Social Studies of Science 34: 161 - 86.
30. Swann, J.P. (1988) Academic Scientists and the Pharmaceutical Industry. Baltimore, MD: Johns Hopkins University Press.
31. Timmermans, K. (2004) 'Harmonization, Regulation and Trade: Intersections in the Pharmaceutical Field', International Journal of Health Services 34: 651 - 61.
32. Vos, R. (1991) Drugs Looking for Diseases. Dordrecht: Kluwer.